Ra Capital Management, L.P. I Teos Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,517,259 shares of ITOS stock, worth $58.7 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
3,517,259Holding current value
$58.7 Million% of portfolio
0.79%Shares
4 transactions
Others Institutions Holding ITOS
# of Institutions
149Shares Held
36.3MCall Options Held
653KPut Options Held
1.48M-
Black Rock Inc. New York, NY3.73MShares$62.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.25MShares$54.3 Million1.7% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$49.2 Million2.43% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$45.7 Million22.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$34.2 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $594M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...